Combined use of ultra-short acting β-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone
- Type
- Retraction
- Notice date
- 5/8/2026 0:00
- Journal
- Expert Opinion on Pharmacotherapy
- Publisher
- Taylor and Francis
- Notice DOI
- 10.1080/14656566.2026.2671545
- Original paper DOI
- 10.1517/14656566.8.13.2135
Reasons
- Cites Retracted Work
- Concerns/Issues about Data
- Concerns/Issues about Results and/or Conclusions
- Investigation by Journal/Publisher